YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
InspireMD, Inc. Q2 2026 Earnings Call Summary - Moby Strategic Recovery and Operational Realignment Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pi…
Major earnings expected before the bell on Monday include: * H World Group Limited (HTHT [https://seekingalpha.com/symbol/HTHT]) * Geely Automobile Holdings Limited (GELYF [https://seekingalpha.com/symbol/GELYF]) * InspireMD (NSPR [https:/…
[Young blond female manager explaining quarterly results on large led screen] NicolasMcComber Next week's earnings calendar is dominated by retail and consumer heavyweights, giving investors a close look at spending trends heading into the…
* InspireMD (NSPR [https://seekingalpha.com/symbol/NSPR]) is scheduled to announce Q2 earnings results on Monday, August 17th, before market open. * The consensus EPS Estimate is -$0.20 [https://seekingalpha.com/symbol/NSPR/earnings/estima…
MIAMI, Aug. 07, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard™ Prime carotid stent system for the prevention of stroke, today announced that the Compensation Committee of In…
InspireMD, Inc. NSPR announced positive 30-day results from the CGUARDIANS II clinical trial evaluating its CGuard Prime 80 cm carotid stent implant for use in transcarotid artery revascularization (TCAR) procedures. The study met key safe…
MIAMI, June 12, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard™ Prime carotid stent system for the prevention of stroke, today announced that the Compensation Committee of In…
Major earnings expected before the bell on Monday include: * Norwegian Cruise Line Holdings Ltd. (NCLH [https://seekingalpha.com/symbol/NCLH]) * Tyson Foods (TSN [https://seekingalpha.com/symbol/TSN]) * Axsome Therapeutics (AXSM [https://s…
(RTTNews) - InspireMD, Inc. (NSPR), the developer of the CGuard Prime carotid stent system, reported fourth-quarter and full-year 2025 financial results that showed solid revenue growth driven by expanding U.S. adoption and steady internat…
Major earnings expected before the bell on Wednesday include: * Tencent Holdings Limited (TCEHY [https://seekingalpha.com/symbol/TCEHY]) * Macy's (M [https://seekingalpha.com/symbol/M]) * General Mills (GIS [https://seekingalpha.com/symbol…
Information technology, industrials and utilities are set to feature prominently in this week’s earnings calendar, with 249 companies scheduled to report. This week’s quant rankings highlight strong momentum among technology and industrial…
Penumbra (PEN) came out with quarterly earnings of $1.18 per share, beating the Zacks Consensus Estimate of $1.12 per share. This compares to earnings of $0.97 per share a year ago. These figures are adjusted for non-recurring items. This…
The CGuard® Prime Carotid Stent System demonstrated the lowest 30-day and 1-year primary endpoint major adverse event rates of any pivotal study of carotid stenting (CAS) MIAMI, Jan. 12, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NS…
MIAMI, Nov. 24, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard® Prime carotid stent system for the prevention of stroke, welcomes the recent presentation and publication of C…
MIAMI, Nov. 21, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that the Compensation Committee of In…
MIAMI, Nov. 19, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced plans to participate in a fireside discussion at the upcoming Piper…
Hologic (HOLX) came out with quarterly earnings of $1.13 per share, beating the Zacks Consensus Estimate of $1.1 per share. This compares to earnings of $1.01 per share a year ago. These figures are adjusted for non-recurring items. This q…
(RTTNews) - InspireMD, Inc. (NSPR), developer of the CGuard Prime carotid stent system for the prevention of stroke, announced Monday the appointment of Peter Soukas as Chief Medical Officer to advance its mission to deliver best-in-class…
MIAMI, Nov. 03, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced the appointment of Peter A. Soukas, M…
Intuitive Surgical, Inc. (ISRG) came out with quarterly earnings of $2.4 per share, beating the Zacks Consensus Estimate of $1.99 per share. This compares to earnings of $1.84 per share a year ago. These figures are adjusted for non-recurr…
MIAMI, Oct. 08, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard®Prime carotid stent system for the prevention of stroke, today announced that the Compensation Committee of Ins…
MIAMI, Sept. 25, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard™ Prime carotid stent system for the prevention of stroke, today announced that the Compensation Committee of I…
InspireMD, Inc. (NASDAQ:NSPR) is among the best fundamentally strong penny stocks to buy right now. According to the latest filing with the SEC, Parkman Healthcare Partners LLC has increased its position in InspireMD, Inc. (NASDAQ:NSPR) by…
Investing.com - InspireMD (NASDAQ: NSPR) reported second quarter EPS of $-0.260, $0.05 worse than the analyst estimate of $-0.210. Revenue for the quarter came in at $1.78M versus the consensus estimate of $1.92M. InspireMD’s stock price c…
--- Management to host investor conference call today, August 5th, at 8:30am ET --- MIAMI, Aug. 05, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke,…
Major earnings expected before the bell on Tuesday include: * Pfizer (PFE [https://seekingalpha.com/symbol/PFE]) * Caterpillar (CAT [https://seekingalpha.com/symbol/CAT]) * BP p.l.c. (BP [https://seekingalpha.com/symbol/BP]) * Organon & Co…
* InspireMD (NASDAQ:NSPR [https://seekingalpha.com/symbol/NSPR]) is scheduled to announce Q2 earnings results on Tuesday, August 5th, before market open. * The consensus EPS Estimate is -$0.26 [https://seekingalpha.com/symbol/NSPR/earnings…
ALISO VIEJO, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced the a…
MIAMI, July 31, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced the appointment of Raymond W. Cohen t…
MIAMI, Fla., July 22, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that it will release its second quarter 2025 financial results…
InspireMD, Inc. NSPR recently announced the official commercial launch of the CGuard Prime Carotid Stent System in the United States, following its premarket application approval from the FDA. This milestone marks a critical step in bringi…
MIAMI - InspireMD, Inc. (NASDAQ:NSPR) announced Wednesday the commercial launch of its CGuard Prime carotid stent system in the United States following FDA premarket application approval. According to InvestingPro data, the company maintai…
MIAMI, June 24, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (the “Company”) (Nasdaq: NSPR), developer of the CGuard Prime Carotid Stent System for the prevention of stroke, today announced that the U.S. Food and Drug Administration (FDA) has…
MIAMI, June 13, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced the company has received CE Mark approval under the European Medical…
MIAMI, June 03, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease and prevention of stroke, today announced the appointment of Michael L…
MIAMI, May 09, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease and prevention of stroke, today announced financial and operating resul…